Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 2115
116th Congress(2019-2020)
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Active
Active
Passed House on Oct 28, 2019
Overview
Text
Introduced
Apr 8, 2019
Latest Action
Oct 29, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2115
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Abigail Spanberger
Virginia
Democrat
Elissa Slotkin
Michigan
Democrat
Jeff Van Drew
New Jersey
Democrat
Brendan Boyle
Pennsylvania
Republican
Jodey Arrington
Texas
Republican
Van Taylor
Texas
House Votes (1)
Senate Votes (0)
checkPassed on October 28, 2019
Question
On Motion to Suspend the Rules and Pass, as Amended
Status
Passed
Type
Roll Call Vote
Roll Call Vote
A vote that records the individual position of each Member who voted. Such votes occurring on the House floor (by the "yeas and nays" or by "recorded vote") are taken by electronic device. The Senate has no electronic voting system; in such votes, Senators answer "yea" or "nay" as the clerk calls each name aloud. Each vote is compiled by clerks and receives a roll call number (referenced in Congress.gov as a "Record Vote" [Senate] or "Roll no." [House]).
Roll Call Type
2/3 Yea-And-Nay
Roll Number
586
House Roll Call Votes
Summary

Public Disclosure of Drug Discounts Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.

Text (3)
Referred in Senate
October 29, 2019
Engrossed in House
October 28, 2019
Introduced in House
April 8, 2019
Related Bills (6)
Dec 19, 2019
Introduced in Senate
10
Sponsorship
Senate Bill 3129
Lower Costs, More Cures Act of 2019
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Dec 09, 2019
Introduced in House
148
Sponsorship
House Bill 19
Lower Costs, More Cures Act of 2019
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Jun 21, 2019
Introduced in House
2
Sponsorship
House Bill 3408
Shop Rx Act of 2019
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Jun 21, 2019
Introduced in House
5
Sponsorship
House Bill 3415
Real-Time Beneficiary Drug Cost Bill
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Apr 12, 2019
Introduced in House
9
Sponsorship
House Bill 2296
More Efficient Tools to Realize Information for Consumers Act
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Apr 08, 2019
Introduced in House
12
Sponsorship
House Bill 2113
Prescription Drug STAR Act
Introduced
Type
Related Bill
Related Bill
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-Congress measures.
Identified By
CRS
Actions (15)
10/29/2019
Received in the Senate and Read twice and referred to the Committee on Finance.
10/28/2019
The title of the measure was amended. Agreed to without objection.
10/28/2019
Motion to reconsider laid on the table Agreed to without objection.
10/28/2019
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586). (text: CR H8516)
10/28/2019
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586).(text: CR H8516)
10/28/2019
Considered as unfinished business. (consideration: CR H8520-8521)
10/28/2019
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
10/28/2019
DEBATE - The House proceeded with forty minutes of debate on H.R. 2115.
10/28/2019
Considered under suspension of the rules. (consideration: CR H8516-8519)
10/28/2019
Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.
05/21/2019
Subcommittee Hearings Held.
04/09/2019
Referred to the Subcommittee on Health.
04/08/2019
Referred to the Subcommittee on Health.
04/08/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
04/08/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 7:17:13 PM
Copyright © 2024 Civic Bits LLC
Privacy Policy
Terms of Service
What's New
About